PROSPECTS FOR THE USE OF PARENTERAL IMMUNOGLOBULINS FOR CORONAVIRUS INFECTION
Abstract
The article is devoted to the use of human immunoglobulin for intravenous administration in patients with
various diseases accompanied by impaired immunity against the background of coronovirus infection (CV). Basic
information about the doses of immunoglobulin used for intravenous administration and methods of infusion of
the drug for various groups of diseases are given. Timely administration of intravenous immunoglobulin in optimal
doses will reduce the duration of therapy for an active infection in patients, as well as reduce the risk of a severe
coronovirus infection with a fatal outcome without the development of serious side effects.
References
2.Aleshkin V.A., Ljutov A.G. Klinicheskoe primenenie immunoglobulina dlja vnutrivennogo vvedenija Gabriglobin. Posobie dlja vrachej. M. 2006. 20 s.
3.Donjush E.K., Ljutov A.G., Soskov G.I. i dr. Ispol'zovanie Gabriglobina (vnutrivennyj immunoglobulin) v lechenii detej s autoimmunnoj trombocitopenicheskoj purpuroj. Voprosy gematologii/onkologii i immunopatologii v pediatrii. 2003; 2 (1): 87-90.
4.Kirgizov K. I., Skorobogatova E. V. Vnutrivennye immunoglobuliny: primenenie sovremennyh fiziologichnyh rastvorov sposobno uluchshit' rezul'taty terapii // RZhDGiO. 2015. №2. S. 77-83.
5.Kuttykuzhanova G.G., Tanirbergenova L.Zh. Primenenie vnutrivennyh immunoglobulinov (pentaglobina) pri infekcionnyh zabolevanijah // Vestnik AGIUV. 2016. №2. 29-32.
6.Latysheva T.V. Vnutrivennye immunoglobuliny (VVIG, IVIG) v klinicheskoj praktike. M.: Jekon-Inform. 2009. 40 s.
7.Onishhenko G.G., Aleshkin V.A., Afanas'ev S.S., Pospelova V.V. Immunobiologicheskie preparaty i perspektivy ih primenenija v infektologii. M.: GOU VUNMC MZ RF. 2002. 608 s.
8.Fesenko I.D. Racional'noe ispol'zovanie immunoglobulina chelovecheskogo normal'nogo dlja vnutrivennogo vvedenija. Pediatricheskaja farmakologija. 2007; 4 (1): 51-55.
9.Ahsan N., Palmer B.F., Wheeler D. et al. Intravenous immunoglobulin-induced osmotic nephrosis. Arch. Intern. Med. 1994; 154: 1985-1987.
10.Burks A.W., Sampson H.A., Buckley R.H. Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. N. Engl. J. Med. 1986; 314: 560-564.
11.Hoffman J.N., Fertmann J.M., Vollmar B. et al. Immunoglobulin M-enriched human intravenous immunoglobulins reduce leukocyte endothelial cell interactions and attenuate microvascular perfusion failure in normotensive endotoxemia. Shock. 2008; 29: 133-139.
CC BY-ND
A work licensed in this way allows the following:
1. The freedom to use and perform the work: The licensee must be allowed to make any use, private or public, of the work.
2. The freedom to study the work and apply the information: The licensee must be allowed to examine the work and to use the knowledge gained from the work in any way. The license may not, for example, restrict "reverse engineering."
2. The freedom to redistribute copies: Copies may be sold, swapped or given away for free, in the same form as the original.
